These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1082456)

  • 61. Specific inhibition of cytotoxic memory cells produced against UV-induced tumors in UV-irradiated mice.
    Thorn RM
    J Immunol; 1978 Nov; 121(5):1920-6. PubMed ID: 81857
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract]   [Full Text] [Related]  

  • 63. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells.
    Williams RM; Germain RN; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD
    Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH; Gurish MF; Daynes RA
    Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cell-mediated allograft responses in vitro. VI. Studies on macrophage-mediated cytotoxicity.
    Pfizenmaier K; Trostmann H; Röllinghoff M; Wagner H
    Immunology; 1975 Dec; 29(6):967-76. PubMed ID: 1081494
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1974 Jun; 112(6):2077-86. PubMed ID: 4207729
    [No Abstract]   [Full Text] [Related]  

  • 69. Cell-mediated immune responses in vitro. II. Simultaneous generation of cytotoxic lymphocyte responses to two sets of alloantigens of limited cross-reactivity.
    Peavy DL; Pierce CW
    J Immunol; 1975 Dec; 115(6):1515-20. PubMed ID: 1184965
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Studies on the cytotoxic effect of in vivo and in vitro immunized lymphocytes on liver target cells.
    Warnatz H; Scheiffarth F; Schmeissner R
    Clin Exp Immunol; 1975 Aug; 21(2):250-8. PubMed ID: 1081024
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Humoral regulation of cell-mediated immunity to syngeneic tumor.
    Ting CC
    Cancer Res; 1976 Oct; 36(10):3695-701. PubMed ID: 953995
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lack of specificity for viral and H-2 antigens by anomalous T killer cells generated in murine leukocyte cultures.
    Shain B; Holt CA; Lilly F
    J Immunol; 1982 Aug; 129(2):722-9. PubMed ID: 6177779
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Natural cytotoxic reactivity of rat lymphocytes against syngeneic Gross virus-induced lymphoma.
    Nunn ME; Djeu JY; Glaser M; Lavrin DH; Herberman RB
    J Natl Cancer Inst; 1976 Feb; 56(2):393-9. PubMed ID: 1082939
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immune responses to weakly immunogenic virally induced tumors. I. Overcoming low responsiveness by priming mice with a syngeneic in vitro tumor line or allogeneic cross-reactive tumor.
    Galili N; Devens B; Naor D; Becker S; Klein E
    Eur J Immunol; 1978 Jan; 8(1):17-22. PubMed ID: 639838
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Manipulation of cytotoxic T lymphocyte responses to syngeneic tumors. I. Hapten-reactive helper T lymphocytes augment tumor-specific CTL responses in vitro.
    Altman A; Bechtold TE; Katz DH
    J Immunol; 1979 Jun; 122(6):2484-90. PubMed ID: 87464
    [No Abstract]   [Full Text] [Related]  

  • 77. Activation of specific cellular immunity toward murine leukemia in mice rejecting syngeneic somatic hybrid cells.
    Liang W; Cohen EP
    J Immunol; 1977 Sep; 119(3):1054-60. PubMed ID: 302270
    [No Abstract]   [Full Text] [Related]  

  • 78. Suppression of natural killer cell activity with radioactive strontium: effector cells are marrow dependent.
    Haller O; Wigzell H
    J Immunol; 1977 Apr; 118(4):1503-6. PubMed ID: 300411
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunogenicity of tumor cells modified by trinitrobenzene suflonic acid (TNBS).
    Kedar E; Unger E; Galili N; Klein G; Asjo B; Bonavida B; Naor D
    Prog Clin Biol Res; 1976; 9():109-21. PubMed ID: 1030796
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Activation of cytotoxic function in T lymphocytes.
    Heininger D; Touton M; Chakravarty AK; Clark WR
    J Immunol; 1976 Dec; 117(6):2175-80. PubMed ID: 136475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.